Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 145Observational 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Carcinoma, Renal Cell 4

Interventions

Surveys and Questionnaires 529Blood Specimen Collection 405Surgical Procedures, Operative 151Interviews as Topic 131Radiotherapy 130Observation 122Drug Therapy 122Magnetic Resonance Spectroscopy 104Biopsy 103Specimen Handling 70Data Collection 70Neoadjuvant Therapy 65Immunohistochemistry 64Magnetic Resonance Imaging 61Immune Checkpoint Inhibitors 58Watchful Waiting 51Immunotherapy 51Bevacizumab 49Positron Emission Tomography Computed Tomography 46Ultrasonography 44Liquid Biopsy 41Hematologic Tests 41Tomography, X-Ray Computed 40Therapeutics 40Radiosurgery 40Colonoscopy 40pembrolizumab 37Hepatectomy 37Gene Expression Profiling 36High-Energy Shock Waves 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Observational × cabozantinib × Clear all
NCT04416646 2026-04-13

ZEBRA

Istituto Oncologico Veneto IRCCS

Completed
100 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT05287464 2025-11-26

International Multicentric Study ARON-1

Hospital of Macerata

Recruiting
1,220 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT06548867 2024-08-12

CABOGEN

Gruppo Oncologico Italiano di Ricerca Clinica

Recruiting
80 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT04510688 2022-10-26

SRWEC

Spanish Oncology Genito-Urinary Group

Completed
275 enrolled
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡